Macrophages, apoptotic cells and cholesterol-strategies for survival: an interview with Dr. Ira Tabas
نویسندگان
چکیده
منابع مشابه
An interview with Dr
Professor of Medicine at the Mayo College of Medicine in Rochester, MN. He has been a consultant in the Division of Pulmonary, Critical Care and Sleep Medicine since 1988 and after receiving all of his training at Mayo, he obtained board certification in all of these subspecialties. He is now president of NAMDRC, Vice-Chair of the ACCP Home Care Network, and a delegate to the ACCP Sleep Institu...
متن کاملJALDA's Interview with Dr. Farshid Sadatsharifi
Farshid Sadatsharifi has been visiting scholar at the Institute of Islamic Studies in McGill University, Montreal, Canada since 2016. He received his PhD and MA in Persian Language and Literature from Shiraz University, Iran. He also completed his post-doc fellowship in Interdisciplinary Approaches to Literature at the same university. Dr. Sadatsharifi is the co-founder and director of Samaak I...
متن کاملInterview with Dr. Hunter
A monoclonal antibody, FBT3, was raised against Tn positive erythrocytes and, using immuno-histochemistry, fresh and fixed tissues from patients with cancer were studied to detect any expression of a Tn-like epitope. Expression was found in neoplastic cells, usually both in cytoplasm and on cell membranes, from 104 of 147 cases of carcinoma and 1 of 13 cases of lymphoma, but rarely in adjacent,...
متن کاملInterview with Dr
Hyperbaric oxygen therapy involves inhaling 100% oxygen at greater than one atmosphere absolute (ATA) in a pressurized chamber. The air we breathe at sea level is defined as 1 ATA. Many of the clinical uses of hyperbaric oxygen therapy (HBOT) have been at pressures above 1.5 ATA. However, recently, some researchers have been using lower pressures of hyperbaric oxygen therapy with good results i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Leukocyte Biology
سال: 2007
ISSN: 0741-5400
DOI: 10.1189/jlb.1307192